BRCA1/BRCA2 Comprehensive (Sequencing And Deletion/Duplication)

This detection assesses both small mutations and large deletions/duplications in the BRCA1 and BRCA2 genes. Identifying these genetic changes helps determine your predisposition to breast and ovarian cancers, assisting in early intervention and prevention strategies.

This test is done primarily:

• To predict the likelihood of developing breast or ovarian cancer
• To guide preventive measures like increased monitoring or prophylactic surgeries
• To make informed treatment decisions if cancer is already present

This test may be recommended in the following circumstances:

• A strong family history of breast or ovarian cancer
• Personal history of breast or ovarian cancer at a young age
• Family members of individuals with known BRCA1/BRCA2 mutations

• Abnormal results and identified mutations indicate higher cancer risk.

Discuss results with your doctor for further evaluation and potential preventive actions.

During the test:

• This test requires a blood sample
• The process is quick and relatively painless
• Minimal discomfort might be experienced during blood draw

There are no specific preparations required for the test. However, it is recommended that you consult with your healthcare provider before taking the test, as they may have specific instructions or recommendations based on your individual medical history and current health status.

Other tests often conducted alongside include:

• Genetic Counselling: Provides insights on managing and understanding hereditary cancer risks.
• Breast MRI: A more detailed imaging technique to screen for breast abnormalities.
• CA 125 Test: Measures the level of CA 125 protein, often elevated in ovarian cancer.

• HBOC Gene Testing
• Hereditary Breast Cancer Testing

Multiple cases of breast and/or ovarian cancer in the same family suggest a diagnosis of hereditary breast and ovarian cancer syndrome (HBOC).This condition involves an increased likelihood of developing breast or ovarian cancer due to inherited genetic mutations, often involving the BRCA1 or BRCA2 genes. Early identification through testing allows for proactive management and preventative strategies.